REDUCTION IN CONTROLLED ATTENUATION PARAMETER AND LIVER STIFFNESS WITH SAROGLITAZAR IN NAFLD: A PROSPECTIVE ANALYSIS. Int. Res. J. Pharm. 2025;16(2):38-49. doi:10.56802/y0zhqk37